Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Málaga
Clinical trial register · Spain

Clinical Trials in Málaga, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca66 Janssen Research & Development, LLC30 Merck Sharp & Dohme LLC29 Hoffmann-La Roche28 Bristol-Myers Squibb26
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Málaga

746 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Ellipses Pharma
Phase 1/2
265
A Coruña, Barcelona, Las Palmas de Gran Canaria, Madrid, Málaga
2022-09-30
Active, closed
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 2
379
Castelló, Málaga, Santander, Valladolid
2022-09-16
Active, closed
AstraZeneca
Phase 3
594
A Coruña, Barcelona, Castellon, Córdoba, Hospitalet deLlobregat, Madrid, Málaga, Ourense
2022-09-15
Recruiting
AstraZeneca
Phase 2
454
Barcelona, Córdoba, Madrid, Málaga, Pamplona, Seville
2022-09-06
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Santiago de Compostela, Palma de Mallorca, L'Hospitalet de Llobregat, Málaga, Oviedo, Barcelona, Granada, Madrid
2022-09-06
Recruiting
ModernaTX, Inc.
Phase 1/2
361
Logroño, Barcelona, Madrid, Málaga
2022-09-01
Active, closed
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
NCT05252988Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive
DrugsColesevelam·Loperamide·Neratinib
Spanish Breast Cancer Research Group
Phase 2
177
Elche, Málaga, Zaragoza, L'Hospitalet de Llobregat, Manresa, Mataró, Castellon, Valladolid
2022-08-31
Recruiting
Bristol-Myers Squibb
Observational
1,700
Palma de Mallorca, Majadahonda, El Palmar, Oviedo, Burgos, Madrid, Málaga
2022-08-16
Active, closed
AstraZeneca
Phase 2
194
Barcelona, Madrid, Málaga, Pamplona, Pozuelo de Alarcón
2022-08-11
Active, closed
AstraZeneca
Phase 3
341
Badajoz, Badalona, Barcelona, Córdoba, Girona, Madrid, Majadahonda, Málaga
2022-08-03
Active, closed
Bausch Health Americas, Inc.
Phase 3
466
Barcelona, Madrid, Málaga, Pontevedra, Valencia, Zaragoza
2022-08-03
Active, closed
Gilead Sciences
Phase 3
443
A Coruña, Barcelona, Bilbao, Lleida, Madrid, Málaga, Murcia, Santa Cruz de Tenerife
2022-07-25
Active, closed
Hoffmann-La Roche
Phase 3
922
Sant Andreu de la Barca, Santiago de Compostela, San Cristóbal de La Laguna, Barcelona, Granada, Huelva, Madrid, Málaga
2022-07-18
Active, closed
Novartis Pharmaceuticals
Phase 1/2
55
Barcelona, Madrid, Málaga
2022-07-13
Active, closed
Daiichi Sankyo
Phase 3
586
A Coruña, Barcelona, Las Palmas de Gran Canaria, Madrid, Málaga, Santander, Seville
2022-07-08
Active, closed
Biohaven Pharmaceuticals, Inc.
Phase 3
269
Donostia / San Sebastian, Esplugues de Llobregat, Málaga, Valencia
2022-07-06
Active, closed
Fundación Canaria Instituto de Investigación Sanitaria de Canarias
Phase 4
80
Barcelona, Málaga, Santa Cruz de Tenerife
2022-07-05
Recruiting
Pfizer
Phase 4
210
A Coruña, Badalona, Barcelona, Santander, Lleida, Majadahonda, Madrid, Málaga
2022-07-05
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
529
A Coruña, Córdoba, Málaga, Santiago de Compostela, Seville, Valencia
2022-06-30
Recruiting
AstraZeneca
Phase 1/2
695
A Coruña, Barcelona, Málaga, Pozuelo de Alarcón, Sant Cugat del Vallès, Seville
2022-06-24
Active, closed
Celgene
Phase 3
939
Pamplona, Barcelona, Cáceres, Córdoba, Madrid, Málaga, Murcia, Oviedo
2022-06-23
Active, closed
Hoffmann-La Roche
Phase 4
136
A Coruña, Barcelona, Madrid, Málaga
2022-06-20
Recruiting
Telios Pharma, Inc.
Phase 1/2
70
Lleida, Madrid, Málaga, Zaragoza
2022-06-09
Recruiting
Astellas Pharma Inc
Phase 1
681
Pamplona, A Coruña, Barcelona, Madrid, Málaga, Seville, Valencia
2022-06-08
Active, closed
ModernaTX, Inc.
Phase 1/2
15
Madrid, Málaga
2022-06-01
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Barcelona, Madrid, Málaga, Santiago de Compostela, Seville
2022-05-23
Active, closed
IO Biotech
Phase 3
407
Seville, A Coruña, Barcelona, Madrid, Málaga, Oviedo, Pamplona, Valencia
2022-05-17
Active, closed
AstraZeneca
Phase 3
644
Barcelona, Granada, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Santiago de Compostela, Seville
2022-05-16
Active, closed
Hoffmann-La Roche
Phase 3
1,300
L'Hospitalet de Llobregat, Salt, Santiago de Compostela, Majadahonda, Bilbao, Barcelona, Madrid, Málaga
2022-05-03
Active, closed
Pierre Fabre Medicament
Phase 3
815
Badalona, L'Hospitalet de Llobregat, El Palmar, Barcelona, Córdoba, Madrid, Málaga, Valencia
2022-05-02
Recruiting
Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
NCT05114850Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Insufficiency, Heart Failure
P+F Products + Features GmbH
Observational
450
Galdakao, Málaga, Barcelona, Córdoba, Lugo, Madrid, Oviedo, Salamanca
2022-04-20
Recruiting
AstraZeneca
Phase 2
630
A Coruña, Alicante, Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Reus
2022-04-14
Active, closed
Verastem, Inc.
Phase 1/2
153
A Coruña, Madrid, Málaga, Seville
2022-04-12
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Barcelona, Madrid, Oviedo, Málaga, Valencia, Zaragoza
2022-03-29
Active, closed
Bayer
Phase 3
219
Esplugues de Llobregat, Barcelona, Madrid, Málaga, Seville
2022-03-28
Active, closed
AstraZeneca
Phase 3
1,035
Barcelona, Córdoba, Lugo, Madrid, Málaga, Sabadell, Seville
2022-03-25
Active, closed
Novo Nordisk A/S
Phase 3
153
El Palmar, Barcelona, Madrid, Málaga
2022-03-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Madrid, Málaga, Barcelona, Seville
2022-03-24
Active, closed
GlaxoSmithKline
Phase 1
152
Barcelona, Madrid, Málaga
2022-03-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Girona, Madrid, Valencia, Barcelona, Lugo, Málaga
2022-03-15
Active, closed
Eli Lilly and Company
Phase 3
368
A Coruña, Palma, Barcelona, El Palmar, Málaga, Pamplona, Reus, Valencia
2022-03-11
Active, closed
Daiichi Sankyo
Phase 2
187
A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville
2022-03-09
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Málaga, Palma de Mallorca, EI Palmar, Barcelona, Cáceres, Madrid, Valencia, La Laguna Tenerife
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Barcelona, Lleida, Madrid, Málaga, Ourense, Seville, Valencia, Zaragoza
2022-03-04
Active, closed
AstraZeneca
Phase 3
390
Barcelona, Málaga, Valencia, Vigo, Zaragoza
2022-02-21
Active, closed
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
NCT05204927Metastasis From Malignant Tumor of Prostate
DrugEnzalutamide
Curium US LLC
Phase 3
439
Madrid, Málaga, Salamanca
2022-02-14
Recruiting
Takeda
Phase 3
120
Esplugues de Llobregat, Sagunto, Madrid, Málaga, Seville
2022-02-10
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
A Coruña, Alicante, Almería, Barcelona, Córdoba, Granada, Madrid, Málaga
2022-02-07
Active, closed
UCB Biopharma SRL
Phase 3
113
Barcelona, Madrid, Málaga, Murcia, Seville
2022-02-02
Recruiting
ARCAGY/ GINECO GROUP
Phase 2
390
A Coruña, Barcelona, Cáceres, El Palmar, Murcia, Jerez de la Frontera, Madrid, Málaga, Oviedo
2022-02-01
Recruiting
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
NCT05098132Advanced Solid Tumor, Non Small Cell Lung Cancer, Untreated Advanced NSCLC, 1st Line NSCLC
DrugsPembrolizumab KEYTRUDA·Pemetrexed·Carboplatin
Synthekine
Phase 1/2
364
Barcelona, Logroño, Madrid, Málaga, Pamplona
2022-01-25
Active, closed
Ascendis Pharma Oncology Division A/S
Phase 1/2
320
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Murcia, Oviedo, Pamplona, Seville
2022-01-11
Active, closed
Novartis Pharmaceuticals
Phase 3
210
Badajoz, Pozuelo de Alarcón, Oviedo, A Coruña, Barcelona, Madrid, Málaga, Zaragoza
2021-12-17
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Barakaldo, Barcelona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Lugo, Madrid, Málaga, Pamplona
2021-12-10
By invitation
QED Therapeutics, a BridgeBio company
Phase 2
300
Madrid, Málaga, Vitoria-Gasteiz
2021-12-06
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Sabadell, Pamplona, Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Málaga
2021-12-02
Active, closed
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
NCT05060016Relapsed/Refractory Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 2
222
Málaga, Barcelona, L'Hospitalet de Llobregat, Majadahonda, Valencia, Madrid
2021-12-01
Active, closed
Hoffmann-La Roche
Phase 3
660
A Coruña, Barcelona, Madrid, Málaga, Seville
2021-11-18
Active, closed
Gilead Sciences
Phase 3
603
A Coruña, Badalona, Barakaldo, Barcelona, Cáceres, Girona, Madrid, Málaga
2021-11-17
Active, closed
Janssen Research & Development, LLC
Phase 3
776
A Coruña, Barcelona, Las Palmas de Gran Canaria, Madrid, Majadahonda, Málaga, Pamplona, Seville
2021-11-17
Active, closed
Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice
NCT04899141Coronary Artery Disease, Ischemic Heart Disease
Fundación EPIC
Observational
400
Málaga, Barakaldo, Barcelona, Cáceres, Ciudad Real, Donostia / San Sebastian, Elche, Galdakao
2021-10-29
Active, closed
AstraZeneca
Phase 3
148
A Coruña, Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Pamplona, Seville
2021-10-28
Active, closed
AstraZeneca
Phase 3
454
L'Hospitalet de Llobregat, Madrid, Málaga, Valencia
2021-10-28
Recruiting
Bayer
Phase 1/2
400
L'Hospitalet de Llobregat, Barcelona, Madrid, Málaga, Valencia
2021-10-25
Active, closed
Camurus AB
Phase 3
332
A Coruña, Barcelona, Elche, Girona, Madrid, Málaga, Murcia, Oviedo
2021-10-22
Active, closed
AstraZeneca
Phase 3
732
A Coruña, Barcelona, Bilbao (Vizcaya), Huelva, L'Hospitalet de Llobregat, Madrid, Málaga, Seville
2021-10-18
Recruiting
AstraZeneca
Phase 1/2
460
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona
2021-10-18
Active, closed
Fondazione Ricerca Traslazionale
Phase 2
105
A Coruña, Barcelona, Madrid, Mataró, Málaga
2021-10-12
Active, closed
Hoffmann-La Roche
Phase 2
176
Barcelona, Madrid, Málaga
2021-10-07
Recruiting
Niguarda Hospital
Phase 3
288
A Coruña, Barcelona, Madrid, Málaga, Murcia
2021-10-07
Active, closed
Hoffmann-La Roche
Phase 3
217
A Coruña, Barcelona, Madrid, Málaga
2021-09-30
Active, closed
Celgene
Phase 1
224
Barcelona, Málaga, Salamanca
2021-09-15
Active, closed
AstraZeneca
Phase 3
98
Alicante, Barcelona, Córdoba, León, Madrid, Málaga, Murcia, Oviedo
2021-09-12
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
NCT05059444Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma, Non-small Cell Lung Cancer
Guardant Health, Inc.
Observational
2,285
A Coruña, Barcelona, Girona, Las Palmas de Gran Canaria, Madrid, Málaga, Sabadell, Santiago de Compostela
2021-09-07
Active, closed
Nuvation Bio Inc.
Phase 2
217
Barcelona, Madrid, Málaga, Seville, Valencia
2021-09-01
Active, closed
Nelum Corp
Phase 1/2
28
Santiago de Compostela, Málaga, Zaragoza, Donostia / San Sebastian, Barcelona, Santander
2021-09-01
Active, closed
Janssen Research & Development, LLC
Phase 4
411
A Coruña, Barakaldo, Barcelona, Bilbao, Córdoba, Madrid, Málaga, Sabadell
2021-08-30
Recruiting
medac GmbH
Phase 3
210
Badalona, Barcelona, Madrid, Málaga, Valencia
2021-08-16
Active, closed
HUYABIO International, LLC.
Phase 3
450
Barcelona, Madrid, Málaga, Seville, Zaragoza
2021-08-12
Recruiting
University Medicine Greifswald
Observational
3,000
Málaga, Valencia
2021-08-06
Recruiting
Philipp Schuetz
Not applicable
1,200
Barcelona, Getafe, León, Madrid, Málaga, Valladolid
2021-08-05
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Barcelona, Madrid, Málaga, Seville, Valencia, Las Palmas de Gran Canaria
2021-08-04
Recruiting
Novartis Pharmaceuticals
Phase 3
98
Barcelona, Port de Sagunt, Madrid, Málaga, Seville
2021-07-28
By invitation
UCB Biopharma SRL
Phase 3
760
Barcelona, Málaga, Sabadell, Vigo
2021-07-27
Active, closed
Janssen Research & Development, LLC
Phase 1
216
Madrid, Málaga
2021-07-13
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 3
434
Alicante, Badajoz, Badalona, Barcelona, Cadiz, Jaén, Madrid, Málaga
2021-07-06
Active, closed
Boehringer Ingelheim
Phase 1
554
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Valencia
2021-07-02
Active, closed
AstraZeneca
Phase 3
315
A Coruña, Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Murcia, Sant Joan Despí
2021-06-30
Active, closed
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
NCT05027984Coronary Artery Disease, Coronary Disease, Ischemic Heart Disease
Centro per la Lotta Contro l'Infarto - Fondazione Onlus
Not applicable
1,425
Málaga, Madrid, Oviedo
2021-06-30
Active, closed
GlaxoSmithKline
Phase 3
40
Barcelona, Cáceres, Córdoba, Granada, Madrid, Málaga, Santiago de Compostela, Valencia
2021-06-28
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Santander, Barcelona, Madrid, Málaga, Pamplona, Oviedo, Valencia
2021-06-25
Active, closed
Janssen Research & Development, LLC
Phase 3
1,054
A Coruña, Córdoba, Madrid, Málaga, Móstoles, Murcia, San Sebastián de los Reyes, Santiago de Compostela
2021-06-17
Active, closed
Novartis Pharmaceuticals
Phase 3
469
Santiago Compostela, L'Hospitalet de Llobregat, El Palmar, Pamplona, Valencia, Barcelona, Madrid, Málaga
2021-06-15
Recruiting
Inmobilization With Compression Bandage vs Antebraquial Splint in Distal Radius Fractures
NCT06019585Distal Radius Fractures, Internal Fixation; Complications, Mechanical
Hospital Costa del Sol
Not applicable
120
Córdoba, Málaga
2021-06-01
Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
NCT04895709Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer, Non-Small-Cell Lung Cancer
DrugsImzokitug·Pumitamig·Docetaxel·Nivolumab
Bristol-Myers Squibb
Phase 1/2
1,109
Málaga, Badalona, Barcelona, Madrid, Pamplona
2021-05-27
Active, closed
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Phase 3
124
Barcelona, Madrid, Málaga, Murcia, Pamplona, Salamanca
2021-05-26
Active, closed
Nobel Biocare
Observational
1,000
Barcelona, Málaga, Palma de Mallorca
2021-05-26
Active, closed
CNS Pharmaceuticals, Inc.
Phase 2
252
Badalona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville
2021-05-18
Active, closed
AstraZeneca
Phase 3
893
Barcelona, Granada, Lleida, Madrid, Málaga, Pamplona, Santiago de Compostela
2021-05-10
Active, closed
ALX Oncology Inc.
Phase 2
172
Barcelona, Badalona, L'Hospitalet de Llobregat, Leganés, Madrid, Málaga, Pamplona
2021-05-10
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
NCT04614103Metastatic Non Small Cell Lung Cancer
DrugLifileucel
Iovance Biotherapeutics, Inc.
Phase 2
170
A Coruña, Barcelona, Córdoba, Madrid, Málaga, Pamplona, Salamanca, Seville
2021-05-07
By invitation
Cytokinetics
Phase 2/3
900
A Coruña, Barcelona, Madrid, Málaga, Palma, Pontevedra, Salamanca, Seville
2021-05-06
Active, closed
ANGiographic Evaluation of Left Main Coronary Artery INtErvention
NCT04604197Coronary Occlusion, Left Main Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease
Fundación EPIC
Not applicable
400
Badalona, Barakaldo, Donostia / San Sebastian, Málaga, Galdakao, A Coruña, Albacete, Alicante
2021-04-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Santander, Barcelona, Girona, Madrid, Málaga
2021-04-14
Active, closed
Eli Lilly and Company
Phase 3
101
Esplugues de Llobregat, Madrid, Málaga, Seville, Valencia
2021-04-13
Active, closed
Geron Corporation
Phase 3
327
Alicante, Badalona, Las Palmas de Gran Canaria, Cáceres, Granada, Madrid, Málaga, Zaragoza
2021-04-12
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Málaga, Barcelona, L'Hospitalet de Llobregat, Pamplona, Palma de Mallorca, Madrid, Valencia
2021-04-08
Active, closed
ALX Oncology Inc.
Phase 2
189
Barcelona, Madrid, Málaga, Pamplona
2021-04-02
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Castellon, Barcelona, Córdoba, Girona, Madrid, Málaga, Seville, Valencia
2021-03-18
Active, closed
Hoffmann-La Roche
Phase 3
746
L'Hospitalet de Llobregat, Pozuelo de Alarcón, EL Palmar (EL Palmar), Vigo, Barcelona, Madrid, Málaga, Seville
2021-03-17
Active, closed
BioNTech SE
Phase 2
327
A Coruña, Ávila, Badalona, Barcelona, Córdoba, Madrid, Majadahonda, Málaga
2021-03-08
Active, closed
German CLL Study Group
Phase 3
897
Badalona, Barcelona, Madrid, Málaga, Oviedo, Salamanca, Santander, Seville
2021-03-01
Active, closed
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
NCT04699188KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Cancer of Lung
DrugsTNO155·Opnurasib·Tislelizumab
Novartis Pharmaceuticals
Phase 1/2
344
Santiago Compostela, L'Hospitalet de Llobregat, Barcelona, Madrid, Málaga, Valencia
2021-02-24
Active, closed
AbbVie
Phase 1
81
Barcelona, Madrid, Majadahonda, Málaga
2021-02-23
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
277
Seville, Badalona, Majadahonda, Barcelona, Madrid, Málaga, Zaragoza
2021-02-02
Active, closed
AstraZeneca
Phase 3
1,371
Barcelona, Jaén, Lleida, Madrid, Málaga, Pamplona, Santander, Seville
2021-01-28
Active, closed
BioNTech SE
Phase 2/3
358
Barcelona, Girona, Jaén, Madrid, Majadahonda, Málaga, Palma de Mallorca, Valencia
2021-01-07
Recruiting
Natural History of Clostridioides Difficile Infection
NCT04801862Clostridium Difficile Infection, Health Care Associated Infection, Nosocomial Infection
Hospital Universitario de Valme
Observational
750
Alicante, Orihuela, Villajoyosa, Puerto Real, Granada, Huelva, Málaga, Valencia
2021-01-01
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
DrugSecukinumab
Novartis Pharmaceuticals
Phase 4
1,000
Santiago Compostela, Málaga, L'Hospitalet de Llobregat, Bilbao, Santander, Vigo, A Coruña, Madrid
2020-12-22
Active, closed
Daiichi Sankyo
Phase 3
605
Barcelona, Madrid, Málaga, Ourense, Seville, Valencia, Zaragoza
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 2
220
A Coruña, Badalona, Barcelona, Cadiz, Granada, Jerez de la Frontera, Madrid, Málaga
2020-12-18
Active, closed
AstraZeneca
Phase 3
358
Barcelona, Madrid, Majadahonda, Málaga
2020-12-16
Active, closed
GlaxoSmithKline
Phase 2/3
758
A Coruña, Badalona, Barcelona, Burgos, Córdoba, Las Palmas de Gran Canar, Madrid, Málaga
2020-12-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
L'Hospitalet de Llobregat, Oviedo, Barcelona, Madrid, Málaga, Seville
2020-12-08
Active, closed
Instituto de Investigación Hospital Universitario La Paz
Phase 1/2
18
Santiago de Compostela, Oviedo, Barcelona, Madrid, Málaga, Murcia, Seville, Valencia
2020-11-30
Active, closed
Hoffmann-La Roche
Phase 3
864
A Coruña, Pozuelo de Alarcón, Vigo, Barcelona, Cadiz, Málaga
2020-11-26
Active, closed
AstraZeneca
Phase 3
957
Barcelona, Madrid, Málaga, Ourense, Santander, Seville, Valencia
2020-11-17
Active, closed
Janssen Research & Development, LLC
Phase 1
136
Madrid, Málaga
2020-11-13
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Cadiz, Ferrol, Jerez de la Frontera, Madrid, Málaga, Pamplona, Seville, Valencia
2020-11-12
Active, closed
AstraZeneca
Phase 1/2
702
Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Seville
2020-11-12
Active, closed
Hoffmann-La Roche
Phase 3
985
A Coruña, Lleida, Pozuelo de Alarcón, Vigo, Barcelona, Cadiz, Madrid, Málaga
2020-10-26
By invitation
Novo Nordisk A/S
Observational
60
Málaga
2020-10-23
Active, closed
Janssen Research & Development, LLC
Phase 3
308
A Coruña, Badalona, Barcelona, Burgos, Madrid, Majadahonda, Málaga, Pamplona
2020-10-13
Active, closed
Hoffmann-La Roche
Phase 3
190
Badalona, Santiago de Compostela, Asturias, Bilbao, Barcelona, Madrid, Málaga, Salamanca
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
A Coruña, Badalona, Barcelona, Burgos, Girona, Madrid, Majadahonda, Málaga
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
696
A Coruña, Barcelona, Castellon, Girona, Jerez de la Frontera, Madrid, Málaga, Sabadell
2020-09-23
Recruiting
University of Birmingham
Phase 1/2
1,672
Barcelona, Bilbao, Madrid, Málaga, Seville, Valencia, Zaragoza
2020-09-17
Active, closed
Women's Cancer Study Group GmbH
Phase 3
1,260
Palma, Barcelona, Cáceres, Elche, Madrid, Manresa, Málaga, Pamplona
2020-09-02
Active, closed
Philogen S.p.A.
Phase 2
98
Madrid, Málaga, San Cristóbal de La Laguna, San Sebastián, Valencia
2020-08-28
Active, closed
Hoffmann-La Roche
Phase 1/2
237
Madrid, Málaga
2020-08-12
Active, closed
Genentech, Inc.
Phase 1
498
Barcelona, Madrid, Málaga, Seville, Valencia
2020-07-29
Active, closed
Baxalta now part of Shire
Observational
207
Palma de Mallorca, Barcelona, Las Palmas, Madrid, Málaga
2020-07-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Majadahonda, Pozuelo de Alarcón, Málaga, Barcelona, Seville, Valencia
2020-07-06
Active, closed
Actelion
Phase 3
935
Barcelona, Madrid, Málaga, Salamanca
2020-06-30
Recruiting
BioInvent International AB
Phase 1/2
197
Barcelona, Majadahonda, Málaga, Pamplona, Seville
2020-06-29
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma
DrugsSigvotatug vedotin·Keytruda·Cisplatin·Carboplatin
Seagen, a wholly owned subsidiary of Pfizer
Phase 1
1,006
Madrid, Elche, Santander, Barcelona, Jerez de la Frontera, Málaga
2020-06-08
Active, closed
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients
NCT04223596Lung Cancer, NSCLC, NSCLC Stage IIIB, NSCLC Stage IV
DrugBrigatinib
Fundación GECP
Phase 2
33
A Coruña, Alicante, Málaga, Palma de Mallorca, Badalona, L'Hospitalet de Llobregat, Barcelona, Las Palmas de Gran Canaria
2020-05-04
Recruiting
Spanish Registry of Esophagogastric Cancer
NCT04958720Esophageal Cancer, Gastric Cancer
Fundación Sociedad Española de Oncologia Médica
Observational
10,000
Alicante, Elche, Elda, Córdoba, Málaga, Seville, Palma de Mallorca, Barcelona
2020-04-27
Active, closed
Modifications to Gastric Sleeve: Implications for GRED and Quality of Life
NCT07070908Obese Patients (BMI ≥ 30 kg/m²), Obese Patients, Obese Patients With Bariatric Surgery, Obese With Comorbidities
Hospital San Juan de Dios Tenerife
Not applicable
120
Málaga
2020-04-06
Active, closed
GlaxoSmithKline
Phase 3
325
Barcelona, L'Hospitalet de Llobrega, Málaga, PamplonaNavarra, Pozuelo de AlarcOn Madr, Santiago de Compostela
2020-04-02
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Barcelona, L'Hospitalet de Llobregat, Girona, Madrid, Málaga, Pamplona, Zaragoza
2020-02-11
Active, closed
GlaxoSmithKline
Phase 1
118
Badalona, Barcelona, Madrid, Málaga, PamplonaNavarra, Pozuelo de AlarcOn Madr, Santander
2019-12-18
Active, closed
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
NCT04183166Squamous Cell Carcinoma of Head and Neck
Transgene
Phase 1/2
80
Barcelona, Madrid, Málaga, Santiago de Compostela
2019-12-12
Recruiting
Medtronic Cardiac Surgery PMCF Registry
NCT04073420Valve Disease, Heart
Medtronic Cardiac Surgery
Observational
2,700
Málaga
2019-12-02
Active, closed
Alnylam Pharmaceuticals
Phase 3
655
L'Hospitalet de Llobregat, Majadahonda, Barcelona, Bilbao, Huelva, Málaga
2019-11-26
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Madrid, Málaga, Oviedo, Seville, Valencia
2019-11-13
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab Beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Balea, Barcelona, Cruces, El Palmar, Madrid, Málaga, San Sebastián, Santiago de Compostela
2019-11-05
Active, closed
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
NCT04036682Non Small Cell Lung Cancer, EGFR Exon 20 Mutation
DrugZipalertinib
Cullinan Therapeutics Inc.
Phase 1/2
284
A Coruña, Barcelona, Las Palmas, Madrid, Málaga, Pamplona, Valencia
2019-10-31
Active, closed
Bristol-Myers Squibb
Phase 3
790
Barcelona, A Coruña, Badalona, Madrid, Málaga, Santander, Valencia
2019-10-28
Active, closed
Novo Nordisk A/S
Phase 3
134
Barcelona, Madrid, Málaga, Oviedo, Seville
2019-10-21
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Badajoz, Barcelona, Madrid, Málaga, Salamanca
2019-10-03
Active, closed
Celgene
Phase 1/2
424
Badalona, Madrid, Málaga, Pamplona, Salamanca, Santander, Valencia
2019-09-30
Active, closed
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Melanoma
DrugsGEN1042·Adrucil·Nab-paclitaxel·Pemetrexed
Genmab
Phase 1/2
350
Barcelona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Lugo, Madrid, Málaga, Pamplona, Santiago de Compostela
2019-09-17
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
San Cristóbal de La Laguna, A Coruña, Alicante, Barcelona, Bilbao, Girona, Madrid, Málaga
2019-08-27
Active, closed
BeOne Medicines
Phase 3
510
Barcelona, Girona, Madrid, Málaga, Seville
2019-08-20
Active, closed
Hoffmann-La Roche
Phase 1/2
498
Barcelona, Madrid, Málaga
2019-08-13
Active, closed
Bristol-Myers Squibb
Phase 3
839
Badalona, A Coruña, Barcelona, Madrid, Málaga, Seville, Valencia
2019-08-05
Recruiting
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NCT03711110Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Elderly, Antineoplastic Agents, Cardiotoxicity
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Not applicable
514
Santiago de Compostela, Galdakao, Barcelona, Córdoba, Madrid, Málaga, Salamanca, Seville
2019-08-02
Active, closed
Tesaro, Inc.
Phase 3
785
Barcelona, Donostia / San Sebastian, Madrid, Málaga, Murcia, Valencia
2019-07-18
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Barcelona, Girona, Jerez de la Frontera, Madrid, Málaga, Seville, Valencia
2019-07-09
Active, closed
AstraZeneca
Phase 3
923
Badalona, Barcelona, Hospitalet deLlobregat, Jaén, Madrid, Málaga, Seville, Valencia
2019-06-25
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
A Coruña, Barcelona, Cadiz, Castellon, Jerez de la Frontera, Madrid, Manacor, Málaga
2019-06-11
Recruiting
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Observational
1,750
Santiago de Compostela, Córdoba, Granada, Huelva, Málaga, Seville, Huesca, Zaragoza
2019-05-21
Active, closed
AbbVie
Phase 1
150
Barcelona, Madrid, Málaga
2019-05-21
Active, closed
Celgene
Phase 1/2
438
Badalona (Barcelona), Barcelona, Madrid, Málaga, Salamanca
2019-05-20
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
DrugsZolbetuximab·Nab-paclitaxel·Gemcitabine
Astellas Pharma Global Development, Inc.
Phase 2
393
Llobregat, Pamplona, Barcelona, Cáceres, Córdoba, Lleida, Madrid, Málaga
2019-03-15
Active, closed
AstraZeneca
Phase 3
724
Badajoz, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, San Sebastián, Santiago de Compostela, Seville
2019-03-06
Active, closed
NVT GmbH
Observational
346
Madrid, Málaga, Salamanca, Vigo
2019-02-20
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Barcelona, Bilbao, Madrid, Málaga, Seville, Valencia, Vigo
2019-02-08
Active, closed
Xenon Pharmaceuticals Inc.
Phase 2
325
Seville, Badalona, Pamplona, Barcelona, Granada, Madrid, Málaga, Valencia
2019-01-30
Active, closed
Janssen Research & Development, LLC
Phase 3
765
A Coruña, Barcelona, Jerez de la Frontera, Madrid, Málaga, Pozuelo de Alarcón, Sabadell, Santander
2019-01-25
Active, closed
Kartos Therapeutics, Inc.
Phase 2
20
Las Palmas de Gran Canaria, Málaga, Salamanca
2019-01-15
Active, closed
AstraZeneca
Phase 2
367
Córdoba, Donostia / San Sebastian, Madrid, Málaga, Valencia, Zaragoza
2019-01-09
Active, closed
Celgene
Phase 3
363
Barcelona, Granada, Madrid, Málaga, Murcia, Ourense, Oviedo, Palma de Mallorca
2019-01-02
Active, closed
AstraZeneca
Phase 3
825
Alicante, Barcelona, Donostia / San Sebastian, Madrid, Málaga, Oviedo, Pamplona, Santiago de Compostela (A Coruña)
2018-12-06
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
507
A Coruña, Barcelona, Elche, Madrid, Málaga, Pamplona, Valencia
2018-11-28
Active, closed
Eli Lilly and Company
Phase 2/3
393
Barcelona, Hospitalet, Madrid, Málaga
2018-11-26
Active, closed
AstraZeneca
Phase 3
895
Barcelona, Girona, Madrid, Málaga, Seville
2018-10-31
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Barakaldo, Barcelona, Madrid, Málaga, Seville
2018-10-29
Active, closed
AbbVie
Phase 2
270
Santiago de Compostela, Badalona, Las Palmas de Gran Canaria, Alcorcón, Ávila, Barcelona, Madrid, Málaga
2018-10-10
Active, closed
Exelixis
Phase 3
187
Barcelona, Madrid, Málaga
2018-10-05
Active, closed
AstraZeneca
Phase 3
1,246
Barcelona, Lugo, Madrid, Málaga, Santander, Seville
2018-09-27
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT03567889Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID
DrugDaromun
Philogen S.p.A.
Phase 3
186
Badalona, Barcelona, Las Palmas de Gran Canaria, Donostia / San Sebastian, Madrid, Málaga, Murcia, Seville
2018-09-20
Recruiting
Sanofi
Phase 2
51
Esplugues de Llobregat, Barcelona, Madrid, Málaga, Valencia
2018-08-09
Active, closed
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
NCT03605771Melanoma Stage Iv, Melanoma Stage Iii, Advanced Cancer
Grupo Español Multidisciplinar de Melanoma
Observational
400
Alcoy, Granada, Málaga, Barcelona, Sabadell, Vitoria-Gasteiz, Santander, Burgos
2018-08-07
Active, closed
AstraZeneca
Phase 3
216
Barcelona, Madrid, Málaga, San Sebastián, Seville, Valencia
2018-07-19
Recruiting
Celgene
Phase 2/3
1,541
Barcelona, Córdoba, Esplugues de Llobregat, Madrid, Málaga, Pamplona, Salamanca, Santander
2018-07-19
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Elche, Madrid, Málaga
2018-07-17
Active, closed
AstraZeneca
Phase 3
1,018
Badajoz, Barcelona, Elche(Alicante), Madrid, Málaga, Oviedo, Pamplona, Pozuelo de Alarcón
2018-05-14
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Alicante, Barcelona, Burgos, Donostia / San Sebastian, Madrid, Málaga, Valencia, Vigo
2018-05-14
Active, closed
Hoffmann-La Roche
Phase 1/2
211
Barcelona, Madrid, Málaga, Valencia
2018-05-08
Active, closed
Corcept Therapeutics
Phase 2
125
Alicante, Girona, Madrid, Málaga, Seville
2018-05-07
Active, closed
MedImmune LLC
Phase 1
400
A Coruña, Barcelona, Majadahonda, Málaga, Pamplona, Valencia
2018-04-24
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
DrugsMevrometostat·Xtandi·Itraconazole·Enzalutamide
Pfizer
Phase 1
453
L'Hospitalet de Llobregat, Castellon, Pozuelo de Alarcón, Barcelona, Madrid, Málaga, Valencia
2018-04-17
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Barcelona, Madrid, Málaga, Ourense, Pontevedra, Pozuelo de Alarcón, Sabadell, Santander
2018-04-05
Active, closed
AstraZeneca
Phase 2
154
Barcelona, Madrid, Málaga, Santiago de Compostela
2018-03-16
Active, closed
Janssen Research & Development, LLC
Phase 2
136
Barcelona, Madrid, Málaga
2018-03-02
Recruiting
Octapharma
Observational
200
Alicante, Barcelona, Málaga, Palma de Mallorca, Valencia
2018-02-13
Active, closed
Gilead Sciences
Phase 3
340
Badalona, Barcelona, Horcajo de la Sierra, Madrid, Málaga, Santander
2017-12-12
Active, closed
BioMarin Pharmaceutical
Phase 3
119
Barcelona, Málaga
2017-12-12
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
61
Badalona, Madrid, Málaga, Salamanca, Valencia
2017-12-01
Active, closed
ViiV Healthcare
Phase 3
1,049
Badalona, Barcelona, Córdoba, Elche Alicante, Madrid, Málaga, Santiago de Compostela, Seville
2017-10-27
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
L'Hospitalet de Llobregat, Santiago de Compostela, Pamplona, Alicante, Barcelona, Madrid, Málaga, Seville
2017-09-22
Active, closed
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.
Phase 1
272
Barcelona, Madrid, Málaga, Pamplona, San Cristóbal de La Laguna, Seville, Valencia
2017-09-20
Active, closed
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
NCT03260023HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Penile Squamous Cell Carcinoma
DrugAvelumab
Transgene
Phase 1/2
143
Badalona, Granada, Madrid, Málaga, Valencia
2017-09-01
Recruiting
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Barcelona, Málaga, Valencia, Badalona, Castellon, Madrid, Oviedo, Zaragoza
2017-07-21
Active, closed
Eli Lilly and Company
Phase 3
5,637
Córdoba, Barcelona, Santiago de Compostela, Lleida, Pozuelo de Alarcón, Alcorcón, Madrid, Málaga
2017-07-12
Active, closed
MedSIR
Phase 2
377
Badalona, L'Hospitalet de Llobregat, Castelló, Jaén, Málaga, Reus, A Coruña, Barcelona
2017-06-26
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Barcelona, Madrid, Málaga, Murcia, Navarro, Salamanca, Santiago, Seville
2017-06-21
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
L'Hospitalet de Llobregat, Barcelona, Elche, Girona, Madrid, Málaga, Valencia, Valladolid
2017-05-03
Active, closed
AbbVie
Phase 3
443
Pamplona, Barcelona, Madrid, Málaga, Valencia
2017-02-02
Active, closed
Janssen Research & Development, LLC
Phase 1/2
234
Badalona, Barcelona, Madrid, Málaga, Pamplona, Seville, Valencia
2016-11-21
Active, closed
ViiV Healthcare
Phase 3
618
Badalona, Barcelona, Córdoba, Elche Alicante, Madrid, Málaga, Santiago de Compostela, Seville
2016-10-28
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Barcelona, Cartagena, Jerez de la Frontera, Madrid, Málaga, San Sebastián de los Reyes, Sant Cugat del Vallès, Seville
2016-09-13
Active, closed
Tesaro, Inc.
Phase 1
463
Barcelona, Girona, Jerez de la Frontera, L'Hospitalet de Llobrega, Las Palmas de Gran Canar, Madrid, Málaga, Palma de Mallorca
2016-07-08
Active, closed
Celgene
Phase 1/2
130
Barcelona, Cáceres, Madrid, Málaga, Valencia
2016-06-03
Active, closed
Janssen Research & Development, LLC
Phase 1
751
A Coruña, Barcelona, Madrid, Málaga, Santander, Seville
2016-05-24
Recruiting
UMC Utrecht
Phase 3
20,000
Barcelona, Cadiz, Córdoba, Madrid, Málaga, Ourense, Santander, Tortosa
2016-04-11
Active, closed
Tesaro, Inc.
Phase 1
729
Santiago de Compostela, Barcelona, Girona, Madrid, Málaga, Murcia, Pamplona, Santander
2016-03-07
Active, closed
MedImmune LLC
Phase 1/2
383
Barcelona, Madrid, Málaga, Pamplona, Seville
2016-02-22
Active, closed
Novartis Pharmaceuticals
Phase 4
233
A Coruña, Barcelona, Madrid, Málaga
2015-12-11
Active, closed
Hoffmann-La Roche
Phase 2
534
Fuenlabrada, Barcelona, Madrid, Málaga, Seville
2015-11-19
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Barakaldo, Barcelona, Castellon, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Reus
2015-11-19
Active, closed
AstraZeneca
Phase 3
682
A Coruña, Barcelona, Donostia / San Sebastian, Elche, Las Palmas de Gran Canaria, Madrid, Majadahonda, Málaga
2015-10-21
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Badalona, Barcelona, Madrid, Málaga, Pamplona, Sabadell, Santander, Santiago de Compostela
2015-04-22
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
El Palmar, Barcelona, Donostia / San Sebastian, Girona, Madrid, Málaga, Oviedo, Palma
2014-12-04
Active, closed
Eli Lilly and Company
Phase 3
453
A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville, Valencia
2014-10-03
Active, closed
UNICANCER
Phase 3
1,173
Badalona, Barcelona, Girona, Madrid, Manresa, Málaga, Sabadell, Salamanca
2013-11-13
Active, closed
AstraZeneca
Phase 3
510
Barcelona, Madrid, Málaga, Seville, Vigo(Pontevedra), Zaragoza
2013-09-25
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Vigo, Barakaldo, Madrid, Málaga, Seville, Valencia
2013-07-26
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Santiago de Compostela, Barakaldo, Logroño, Burela de Cabo, Málaga, Oviedo, Reus, A Coruña
2013-05-30
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Barcelona, Málaga, Murcia, Oviedo
2013-04
Active, closed
Medtronic Cardiovascular
Not applicable
1,746
Málaga, Oviedo
2012-04
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
A Coruña, Córdoba, Elche, Girona, Granada, L'Hospitalet de Llobregat, Madrid, Málaga
2012-01
Active, closed
AstraZeneca
Phase 3
736
A Coruña, Madrid, Málaga, Oviedo, Salamanca, Seville
2005-02-13
Active, closed
Fundacion IMIM
Observational
500
Hospitalet Llobregat,, L'Hospitalet de Llobregat, Sant Cugat del Vallès, San Sebastián, A Coruña, Barcelona, Madrid, Málaga
2003-04
Rows per page Showing 501–746 of 746
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/m-laga?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 746 of those studies with a site in Málaga.

How many clinical trials are recruiting in Málaga?

367 of the 746 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 25 have not yet opened recruitment, 339 are active but closed to new participants, and 15 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.